Dr Reddy's acquires Spain's Litaphar

Published on Mon, Sep 18, 2006 at 13:32 |  Source : Moneycontrol.com

Updated at Mon, Sep 18, 2006 at 22:25  

27064 Investors following Dr Reddys Labs. Share this News with them.
0
0
Share on Tumblr
Markets Midday

Excerpts from Markets Midday on CNBC-TV18 Watch the full show ยป

ALSO READ

Dr Reddy's Laboratories has acquired a company in Spain to enter the fast emerging generic market, reports CNBC-TV18.

 

The company had acquired Spain based generic company, Litaphar in May 2006, but this was kept under wraps till now. The company, in its annual report mentioned that this deal was done for 3.5 million euros.

 

Litaphar has annual sales of 1 million euros. Experts believe the acquisition is a strategic fit for the company to enter emerging generic markets. They expect more acquisitions in other emerging markets like Italy.

  

More on Moneycontrol

Trending News

Business News

Windows 8 Consumer Preview arriving on Feb 29
Competition ahoy: Monkey 1, Sensex in neck-and-neck race "Competition ahoy: Monkey 1, Sensex in neck-and-neck race"

From DJ Greek Fin Min Says Feb 17 Final Day For Greek Bond Exchange Offer

The latest earning numbers FIRST on CNBC-TV18
Videos

Feb 12 2012, 11:20

See more rally even if Greek crisis drags on: RBS

- in FII View

Feb 10 2012, 21:39

Truck demand sluggish; margins down 80bps: Shriram Trans

- in Results Boardroom

Interviews

Feb 11 2012, 11:52 | Source: CNBC-TV18

TCS to expand centers in N.America; CY12 focus on Japan  

Feb 10 2012, 15:43 | Source: CNBC-TV18

Growth in margins sustainable going forward: Shasun Pharma  

Subscribe to

Moneycontrol Newsletters

Moneycontrol.com offers you a choice of various sectoral and other newsletters for FREE!

Follow moneycontrol.com